| Product NDC: | 0004-0298 |
| Proprietary Name: | CellCept |
| Non Proprietary Name: | Mycophenolate Mofetil hydrochloride |
| Active Ingredient(s): | 500 mg/20mL & nbsp; Mycophenolate Mofetil hydrochloride |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0004-0298 |
| Labeler Name: | Genentech, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050758 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19981001 |
| Package NDC: | 0004-0298-09 |
| Package Description: | 4 VIAL in 1 CARTON (0004-0298-09) > 20 mL in 1 VIAL |
| NDC Code | 0004-0298-09 |
| Proprietary Name | CellCept |
| Package Description | 4 VIAL in 1 CARTON (0004-0298-09) > 20 mL in 1 VIAL |
| Product NDC | 0004-0298 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Mycophenolate Mofetil hydrochloride |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19981001 |
| Marketing Category Name | NDA |
| Labeler Name | Genentech, Inc. |
| Substance Name | MYCOPHENOLATE MOFETIL HYDROCHLORIDE |
| Strength Number | 500 |
| Strength Unit | mg/20mL |
| Pharmaceutical Classes | Antimetabolite Immunosuppressant [EPC] |